Abstract:
An organometallic compound represented by Formula 1:
M1(L1)n1(L2)n2 Formula 1
wherein, M1 is a transition metal, L1 is ligand represented by Formula 1A, L2 is a ligand represented by Formula 1B, and n1 and n2 are each independently 1 or 2:
wherein X1 to X4 are each independently C or N; Y1 is O, S, Se, C(R5)(R6), N(R7), or Si(R8)(R9); ring CY2 and ring CY4 are each independently a C5-C30 carbocyclic group or a C1-C30 heterocyclic group; ring CY3 is a 5-membered heterocyclic group, a 5-membered heterocyclic group condensed with a C5-C30 carbocyclic group, or a 5-membered heterocyclic group condensed with a C1-C30 heterocyclic group; * and *′ each indicate a binding site to M1; and the remaining descriptions of Formulae 1A and 2B as described herein.
Abstract:
An organometallic compound, represented by Formula 1: M1(Ln1)n1(Ln2)n2 Formula 1 wherein, Ln1 is a ligand represented by Formula 1-1, Ln2 is a ligand represented by Formula 2-1 or 2-2, n1 is 1, 2, or 3, and n2 is 0, 1, or 2, wherein CY1 is a benzoquinoline group or a benzoisoquinoline group, X31 and X32 are each independently O or S; R10, R21 to R28, R31 to R37, R41 to R44, and b10 are as defined herein; and * and *′ each indicate a binding site to M1.
Abstract:
An organometallic compound represented by Formula 1: wherein, in Formula 1, groups and variables are the same as described in the specification.
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2 Formula 1 wherein L1 is a ligand represented by Formula 2 and L2 is a ligand represented by Formula 3; wherein in Formulae 1, 2, and 3, groups and variables are defined in the specification.
Abstract:
An organometallic compound represented by Formula 1: wherein, in Formula 1, R37 is hydrogen, deuterium, a substituted or unsubstituted C1-C60 alkyl group, a substituted or unsubstituted C3-C10 cycloalkyl group, a substituted or unsubstituted C2-C10 heterocycloalkyl group, a substituted or unsubstituted C6-C60 aryl group, a substituted or unsubstituted C2-C60 heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group; and ring CY1, R21 to R26, R30a, and R30b, are as described herein.
Abstract:
Provided are an organometallic compound represented by Formula 1, an organic light-emitting device including the same, and an electronic apparatus including the organic light-emitting device: wherein, in Formula 1, Y2, ring CY1, ring CY2, T1, T2, A1 to A7, a1, and a2 are as defined in the specification.
Abstract:
An organometallic compound represented by Formula 1: wherein, Formula 1, R1 to R10 and A1 to A7 are the same as described in the detailed description of the specification.
Abstract:
An organometallic compound represented by Formula 1: M(L1)n1(L2)n2 Formula 1 wherein in Formula 1, L1 is a divalent ligand represented by Formula 2, L2 is selected from a monovalent organic ligand, a divalent organic ligand, and trivalent organic ligand, and L2 is not a ligand represented by Formula 2; wherein in Formulae 1 and 2, M, CY1, CY2, Y1, Y2, Z1, a1, n1, and n2 are the same as described in the specification.